Quatrefolic (5-MTHF Glucosamine).

Methionine synthase moves the methyl group from 5-methyltetrahydrofolate onto cobalamin and then onto homocysteine. Without B12 the methylfolate cannot unload, and the folate pool sits trapped in its methylated form.

Cobalamin is the intermediate carrier for the methyl group that 5-MTHF donates. Supplying reduced folate without cobalamin leaves the transfer step short of its carrier.

Methylfolate remethylates homocysteine back to methionine while pyridoxal 5-phosphate clears it down the transsulfuration branch. Covering both routes keeps the metabolite moving in either direction.

MTHFR uses FAD made from riboflavin to produce 5-methyltetrahydrofolate. Supplying the finished 5-MTHF bypasses that step, and riboflavin still matters for the rest of the endogenous folate cycle.

Folic acid must be reduced by dihydrofolate reductase, a slow human step, and unreduced folic acid competes with reduced folates for the same cell transporters and binding proteins. Dosing both together means two forms contending for one entry path.

Quatrefolic is a glucosamine salt of (6S)-5-methyltetrahydrofolate, the same active molecule delivered by other methylfolate salts. Doses add rather than complement, so a formula carrying both is stacking one nutrient.

Both entries land in the same tetrahydrofolate pool used for one-carbon transfers. Total folate intake is what matters, not the sum of separate label lines.

Choline oxidised to betaine offers a folate-independent way to remethylate homocysteine, and low folate raises the demand on choline for that job. The two pools substitute for each other in one-carbon supply.

Betaine-homocysteine methyltransferase remethylates homocysteine without folate or B12. It runs in parallel with the methylfolate route and takes load off it.

Methionine made by the folate-dependent step is adenosylated to SAM-e, the cell's main methyl donor, and SAM-e in turn inhibits MTHFR as a feedback signal. They sit on either side of one methylation cycle.

Serine hands its beta-carbon to tetrahydrofolate through serine hydroxymethyltransferase, which is the principal source of one-carbon units. Folate is the carrier and serine is the cargo.

The glycine cleavage system loads a one-carbon unit onto tetrahydrofolate, and serine hydroxymethyltransferase releases glycine while doing the same. Glycine is both a source for and product of the folate pool.

Methionine synthase and the intestinal folate conjugase are zinc-dependent, so zinc status affects folate handling. Large folate doses have also been shown to affect zinc absorption, making this a two-way interaction.

Folate supplies the one-carbon units for DNA synthesis in dividing erythroid cells while iron is inserted into heme. Normal red blood cell formation needs both arms present.

Reduced folates oxidise readily and ascorbate slows that loss in the gut lumen and in solution. It is a stability effect rather than a metabolic one.

The methionine that 5-MTHF helps regenerate is converted onwards to S-adenosylmethionine by an ATP-dependent enzyme that requires the Mg-ATP complex. Magnesium status therefore sits immediately downstream of the folate step. The dependency is structural rather than dose-related.

Both dihydrofolate reductase and methylenetetrahydrofolate reductase use NADPH, which is built on the nicotinamide nucleotide pool. Supplying folate already in its reduced methylated form bypasses those reductions, so the NADPH requirement applies to folic acid and not to 5-MTHF. That is a difference in which enzymes each form needs, not a statement that one form is preferable.

5-MTHF donates its methyl group to homocysteine to regenerate methionine, so methionine is the direct product of the reaction folate drives. A high methionine load pushes the cycle in the opposite direction and increases homocysteine flux into transsulfuration. The pairing is the two ends of one reaction.

Several bifidobacteria synthesise folates de novo and release them into the colonic lumen, where some is absorbed. The amount contributed varies by strain and is small next to an oral dose. It is a genuine additional source rather than an effect on the supplement itself.

Catechins including EGCG inhibit dihydrofolate reductase in laboratory assays, which is the enzyme that reduces folic acid to its usable form. A pre-reduced 5-MTHF salt does not need that enzyme, so the interaction bears more on folic acid. The work is in vitro and the human relevance at dietary intakes has not been established.

Endogenous creatine synthesis consumes a large share of the body's S-adenosylmethionine methyl groups, which the folate cycle helps replenish. Supplying creatine directly lowers that demand. The two therefore act on the same methyl budget from opposite sides.

Myo-inositol and methylfolate are routinely combined in the same products, and both are involved in normal reproductive and metabolic signalling. The pairing is a formulation convention with separate rationales for each ingredient rather than a demonstrated interaction between them. Confidence is set accordingly.

5-MTHF participates in the regeneration of tetrahydrobiopterin, the cofactor that tyrosine hydroxylase needs to convert tyrosine to L-DOPA. Folate status therefore sits upstream of catecholamine synthesis, with tyrosine supplying the substrate. The connection is mechanistic and the size of any effect in normally nourished people is not established.

Tryptophan hydroxylase is the tetrahydrobiopterin-dependent step that 5-HTP bypasses, and 5-MTHF contributes to keeping that cofactor in its reduced form. Taking 5-HTP steps past the point where folate status matters most. The two are linked through the same cofactor rather than acting together.

MTHFR is a flavoprotein that needs FAD from riboflavin to make 5-MTHF from its methylene precursor. Supplying 5-MTHF directly sits downstream of that requirement, which is why riboflavin status matters more for other folate forms. The reduced-activity MTHFR variant is more sensitive to riboflavin status than the common form.

The glucosamine in this salt is the counter-ion that carries the 5-MTHF anion, not an active in its own right at the amounts present. Anyone counting glucosamine intake across a stack should regard the contribution from a folate salt as negligible but not zero. It is a labelling point rather than a pharmacological one.